Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 16,675.0 | $4.3M | 0.53% | -8K | -33.3% | $258.32 | +12.9% |
| 62 | DOCS | DOXIMITY INC | Healthcare | 183,808.0 | $4.3M | 0.53% | -189K | -50.7% | $23.30 | -16.0% |
| 63 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 59,000.0 | $4.2M | 0.52% | NEW | — | $71.95 | -4.9% |
| 64 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 199,000.0 | $3.8M | 0.47% | +99K | +99.0% | $19.20 | -4.2% |
| 65 | STVN | STEVANATO GROUP S P A | Healthcare | 274,676.0 | $3.8M | 0.47% | +128K | +86.8% | $13.75 | +29.4% |
| 66 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 360,000.0 | $3.6M | 0.44% | -100K | -21.7% | $9.95 | +21.6% |
| 67 | — | COOPER COS INC | — | 50,000.0 | $3.6M | 0.44% | -278K | -84.7% | $71.50 | — |
| 68 | SION | SIONNA THERAPEUTICS INC | Healthcare | 87,500.0 | $3.5M | 0.43% | NEW | — | $40.09 | -2.1% |
| 69 | — | ASCENDIS PHARMA A/S | — | 15,000.0 | $3.4M | 0.42% | — | — | $228.73 | — |
| 70 | DHR | DANAHER CORPORATION | Healthcare | 18,052.0 | $3.4M | 0.42% | -81K | -81.8% | $189.60 | -13.6% |
| 71 | PODD | INSULET CORP | Healthcare | 14,000.0 | $2.9M | 0.36% | -47K | -77.0% | $209.84 | -27.3% |
| 72 | A | AGILENT TECHNOLOGIES INC | Healthcare | 25,000.0 | $2.8M | 0.35% | +5K | +25.0% | $113.98 | -3.0% |
| 73 | STOK | STOKE THERAPEUTICS INC | Healthcare | 83,000.0 | $2.7M | 0.33% | -133K | -61.6% | $32.56 | -10.8% |
| 74 | ESPR | ESPERION THERAPEUTICS INC NE | Healthcare | 985,000.0 | $2.7M | 0.33% | NEW | — | $2.74 | +14.2% |
| 75 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 85,724.0 | $2.6M | 0.32% | -68K | -44.1% | $30.15 | -5.9% |
| 76 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 305,000.0 | $2.6M | 0.32% | +40K | +15.1% | $8.47 | -1.1% |
| 77 | STE | STERIS PLC | Healthcare | 11,500.0 | $2.5M | 0.31% | +6K | +91.7% | $221.13 | -3.7% |
| 78 | VCEL | VERICEL CORP | Healthcare | 70,000.0 | $2.3M | 0.28% | -47K | -40.2% | $32.17 | +8.4% |
| 79 | KURA | KURA ONCOLOGY IN | Healthcare | 271,500.0 | $2.2M | 0.27% | -600K | -68.9% | $8.13 | +13.2% |
| 80 | CI | THE CIGNA GROUP | Healthcare | 8,000.0 | $2.1M | 0.26% | -31K | -79.3% | $266.75 | +9.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%